Physician

Elia C Mavrofrides, MD

According to 2025 Medicare claims, Elia Mavrofrides, MD (NPI: 1396745105) practices ophthalmology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 32159-4540.

Mavrofrides' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,149 traditional Medicare patients, billed 68,307 HCPCS/CPT codes, and received $6,481,407 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 2,188 prescription claims across 613 beneficiaries totaling $528,632 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 33 records totaling $1,111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,830,263 to $6,481,407. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $260,451 and ending at $528,632. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.2M$6.5M2015 Medicare payment: $2,830,263 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,136,566 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,165,605 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,301,265 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,006,555 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,901,010 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,947,542 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,442,779 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,243,653 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,481,407 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,25026,865$2,830,263
20162,20130,164$3,136,566
20172,23927,990$3,165,605
20182,32631,614$4,301,265
20192,27130,377$5,006,555
20202,09926,749$4,901,010
20212,21527,861$4,947,542
20222,33336,925$5,442,779
20232,29566,858$6,243,653
20242,14968,307$6,481,407

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$347K$693K2015 Drug cost: $260,451 (USD; Tot_Drug_Cst)2016 Drug cost: $404,631 (USD; Tot_Drug_Cst)2017 Drug cost: $660,099 (USD; Tot_Drug_Cst)2018 Drug cost: $419,718 (USD; Tot_Drug_Cst)2019 Drug cost: $603,958 (USD; Tot_Drug_Cst)2020 Drug cost: $693,175 (USD; Tot_Drug_Cst)2021 Drug cost: $521,124 (USD; Tot_Drug_Cst)2022 Drug cost: $393,321 (USD; Tot_Drug_Cst)2023 Drug cost: $600,918 (USD; Tot_Drug_Cst)2024 Drug cost: $528,632 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154241,576$260,451
20164571,615$404,631
20174861,751$660,099
20184911,845$419,718
20194591,939$603,958
20205232,072$693,175
20215291,981$521,124
20225511,951$393,321
20235832,147$600,918
20246132,188$528,632

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye7523,053$97
92014Established patient complete exam of visual system1,0481,087$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,1121,692$62
92134Imaging of retina1,1773,059$29
92250Photography of the retina1,8052,064$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept962,688$223,660
SyfovrePegcetacoplan/Pf24600$76,665
LucentisRanibizumab20560$49,140
Prednisolone AcetatePrednisolone Acetate51327,918$21,457
Loteprednol EtabonateLoteprednol Etabonate703,528$14,065

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$1,111Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Elia C. Mavrofrides, MD?

Tedicare shows public-source Medicare data for Elia C. Mavrofrides, MD (NPI 1396745105), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elia C. Mavrofrides, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Elia C. Mavrofrides, MD?

Elia C. Mavrofrides, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Elia C. Mavrofrides, MD have Open Payments data?

Elia C. Mavrofrides, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.